After Rajasthan, Gujarat to test J&J's baby shampoos

The test results are likely to be out in another two to three weeks

Johnson and Johnson
Gujarat's move to test the baby shampoo product is not driven by any larger steps being taken by the Drug Controller General of India (DCGI) at the Centre.
Vinay Umarji Ahmedabad,
3 min read Last Updated : Apr 04 2019 | 1:14 PM IST
After Rajasthan's state drugs controller found that Johnson & Johnson (J&J)'s baby shampoo products were not of standard quality, the Gujarat Food and Drugs Control Authority has turned its eye on the healthcare major. 

The state FDCA has now ordered tests on samples of J&J's baby shampoo results, which could take at least couple of weeks. 

Gujarat took it upon itself to test the products following media reports on results in Rajasthan. 

"We randomly and arbitrarily take up products for test. Close to 15,000 samples of drugs and cosmetics every year are tested in Gujarat. However, we have now ordered tests on Johnson & Johnson's baby shampoos on a priority basis after we saw the results declared by Rajasthan," H G Koshia, Food and Drugs Commissioner of Gujarat told Business Standard.

Recently, Rajasthan Drugs Control Organisation termed J&J's baby shampoo products as non-standard quality after the state drug controller found carcinogenic contents in two batches of the samples tested. Having discovered formaldehyde, a carcinogen, in the samples tested, Rajasthan's drug controller has asked its officials to ensure that J&J's baby shampoo stocks were not consumed anymore. Responding to the findings, J&J has contested the interim test results of the analysis that were based on “unknown and unspecified methods.” Further, it added, “the application before the relevant authority is pending for re-testing of samples at Central Drugs Laboratory.”

As for tests in Gujarat, Koshia said that test results are likely to be out in the next 2-3 weeks. 

However, Gujarat's move to test the baby shampoo product is not driven by any larger steps being taken by the Drug Controller General of India (DCGI) at the Centre. 

"We have taken the step suo moto and have not heard or received any notification from the DCGI," Koshia added.

As per a company spokesperson, J&J has challenged the interim test results of Rajasthan and called for retesting of samples at Central Drugs Laboratory. "We unequivocally maintain that our products are safe and our assurance process is amongst the most rigorous in the world, meeting or exceeding the safety standards in every country where our products are sold. Johnson & Johnson is in full compliance with current Indian regulatory requirements and standards for manufacturing and testing of all our products," a J&J spokesperson stated.

"Earlier this year, representatives of the Drug Controller in Jaipur, Rajasthan drew samples of Johnson’s Baby Shampoo for testing and we fully co-operated during the process.  We do not accept the interim results given to us which mentioned samples to ‘contain harmful ingredients- identification positive for formaldehyde.’ The government did not disclose the test methods, details or any quantitative findings. This is concerning especially when there is no prescribed test method or requirement for testing Formaldehyde in shampoo under the applicable standards.  We have confirmed to the Indian authorities that we do not add Formaldehyde as an ingredient in our shampoo nor does Johnson’s baby shampoo contain any ingredient that can release formaldehyde over time. Our products are safe to use and conform to all applicable standard under the D&C Act and D&C rules," the company spokesperson further stated. 
_______________________________________________________________________________________________________The story has been amended to add J&J's response.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story